CRISPR and Cas is a unique technology which enables researchers to edit parts of the genome by either adding, removing, or altering sections of the DNA sequence. CRISPR and Cas is known as clustered regularly interspaced short palindromic repeats occurring in the genome of bacteria.
Rise in government and private investments for development of novel therapies is the key driving factor which is expected to boost the global CRISPR and Cas genes market growth. Furthermore, rise in focus on development of novel therapeutics and increase in prevalence of various genetic disorders and cancer will have the positive impact on market growth. Moreover, Increase in technological advancements is expected to propel the global CRISPR and Cas genes market growth.
Market Restraints
However, high costs associated with use of CRISPR are major restraining factor which is expected to hamper the global CRISPR and Cas genes market growth. Also, ethical concerns regarding human genome editing will affect the market growth.
Global CRISPR and Cas Genes Market is segmented into product such as DNA-Free Cas, and Vector-Based Cas, by application such as Genome Engineering, Functional Genomics, Disease Models, and Knockdown/Activation. Further, market is segmented into end user such as Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Academic & Government Research Institutes.
Also, Global CRISPR and Cas Genes Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key Players are discussed in this report such as GE Healthcare, Intellia Therapeutics, Horizon Discovery Group, Thermo Fisher Scientific, Takara Bio USA, Editas Medicine, Mirus Bio LLC, Merck KGaA, and CRISPR THERAPEUTICS
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
5.2 Global CRISPR and Cas Genes Market Share Analysis, By Product
5.3 Global CRISPR and Cas Genes Market Size and Forecast, By Product
5.3.1 DNA Free Cas
5.3.2 Vector Based Cas
6.2 Global CRISPR and Cas Genes Market Share Analysis, By Application
6.3 Global CRISPR and Cas Genes Market Size and Forecast, By Application
6.3.1 Genome Engineering
6.3.2 Functional Genomics
6.3.3 Knockdown/Activation
7.2 Global CRISPR and Cas Genes Market Share Analysis, By End User
7.3 Global CRISPR and Cas Genes Market Size and Forecast, By End User
7.3. 1 Biotechnology & Pharmaceutical Companies
7.3.2 Contract Research Organizations
7.3.3Academic & Government Research Institutes
8.2 Global CRISPR and Cas Genes Market Share Analysis, By Region
8.3 Global CRISPR and Cas Genes Market Size and Forecast, By Region
9.2 North America CRISPR and Cas Genes Market Share Analysis, By Product
9.3 North America CRISPR and Cas Genes Market Size and Forecast, By Application
9.4 North America CRISPR and Cas Genes Market Size and Forecast, By End User
9.5 North America CRISPR and Cas Genes Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10.2 Europe CRISPR and Cas Genes Market Share Analysis, By Product
10.3 Europe CRISPR and Cas Genes Market Size and Forecast, By Application
10.4 Europe CRISPR and Cas Genes Market Size and Forecast, By End User
10.5 Europe CRISPR and Cas Genes Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific CRISPR and Cas Genes Market Analysis and Forecast (2017 – 2030)
11.1 Introduction
11.2 Asia Pacific CRISPR and Cas Genes Market Share Analysis, By Product
11.3 Asia Pacific CRISPR and Cas Genes Market Size and Forecast, By Application
11.4 Asia Pacific CRISPR and Cas Genes Market Size and Forecast, By End User
11.5 Asia Pacific CRISPR and Cas Genes Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12.2 Latin America CRISPR and Cas Genes Market Share Analysis, By Product
12.3 Latin America CRISPR and Cas Genes Market Size and Forecast, By Application
12.4 Latin America CRISPR and Cas Genes Market Size and Forecast, By End User
12.5 Latin America CRISPR and Cas Genes Market Size and Forecast, Country
13.2 Middle East CRISPR and Cas Genes Market Share Analysis, By Product
13.3 Middle East CRISPR and Cas Genes Market Size and Forecast, By Application
13.4 Middle East CRISPR and Cas Genes Market Size and Forecast, By End User
13.5 Middle East CRISPR and Cas Genes Market Size and Forecast, By Country
15.1 GE Healthcare
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Intellia Therapeutics
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Horizon Discovery Group
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Thermo Fisher Scientific
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Takara Bio USA
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Editas Medicine
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Mirus Bio LLC
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Merck KGaA
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 CRISPR THERAPEUTICS
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
